Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters










Publication year range
1.
Cancer Lett ; 597: 217070, 2024 Aug 10.
Article in English | MEDLINE | ID: mdl-38880227

ABSTRACT

The androgen receptor signaling inhibitor (ARSI) enzalutamide (Enz) has shown critical efficacy in the treatment of advanced prostate cancer (PCa). However, the development of drug resistance is a significant factor contributing to mortality in PCa patients. We aimed to explore the key mechanisms of Enz-resistance. Through analysis of GEO databases, we identified SLC4A4 as a novel driver in Enz resistance. Long-term Enz treatment leads to the up-regulation of SLC4A4, which in turn mediates P53 lactylation via the NF-κB/STAT3/SLC4A4 axis, ultimately leading to the development of Enz resistance and progression of PCa. SLC4A4 knockdown overcomes Enz resistance both in vitro and in vivo. Hence, our results suggest that targeting SLC4A4 could be a promising therapeutic strategy for Enz resistance. STATEMENT OF SIGNIFICANCE: SLC4A4 is a novel driver of enzalutamide resistance.


Subject(s)
Benzamides , Drug Resistance, Neoplasm , Nitriles , Phenylthiohydantoin , Prostatic Neoplasms , Sodium-Bicarbonate Symporters , Animals , Humans , Male , Mice , Cell Line, Tumor , Drug Resistance, Neoplasm/genetics , Gene Expression Regulation, Neoplastic/drug effects , NF-kappa B/metabolism , NF-kappa B/genetics , Phenylthiohydantoin/pharmacology , Phenylthiohydantoin/therapeutic use , Phenylthiohydantoin/analogs & derivatives , Prostatic Neoplasms/drug therapy , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , Signal Transduction/drug effects , STAT3 Transcription Factor/metabolism , STAT3 Transcription Factor/genetics , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , Up-Regulation , Xenograft Model Antitumor Assays , Sodium-Bicarbonate Symporters/genetics
2.
Medicine (Baltimore) ; 103(21): e38056, 2024 May 24.
Article in English | MEDLINE | ID: mdl-38788046

ABSTRACT

RATIONALE: Intimal sarcoma of inferior vena cava (IVC) is a rare soft tissue sarcoma with no typical symptoms and specific imaging features in the early stage, and there is a lack of standardized treatment and methods. PATIENT CONCERNS: A 54-year-old female patient presented to Fenghua District People's Hospital with a post-active cough and hemoptysis and was subsequently referred to our hospital. DIAGNOSES: The patient was pathologically diagnosed as intimal sarcoma of IVC complicating multiple intrapulmonary metastases. Chest CT revealed left lung malignant tumor with multiple intrapulmonary metastases; while enhanced upper abdominal CT showed cancer embolus of IVC with extension to right atrium and bilateral renal veins. Besides, hematoxylin and eosin staining suggested intimal sarcoma of veins. Immunohistochemical staining showed positivity for PD-L1, Ki-67, CD31, Desmin and ERG. INTERVENTIONS: The patient initially received GT chemotherapy (gemcitabine injection + docetaxel). Then, immunotherapy (tislelizumab) was added based on the results of genetic testing (TP53 gene mutation). OUTCOMES: The disease was stabilized after receiving the treatment. LESSONS: Given the lack of characteristic clinical manifestations in patients with intimal sarcoma of IVC, imaging examination combined with immunohistochemical index were helpful for diagnosis of intimal sarcoma of IVC. Furthermore, the combination of tislelizumab and GT chemotherapy was feasible in such patients with positive PD-L1 expression and TP53 mutation.


Subject(s)
Antibodies, Monoclonal, Humanized , Sarcoma , Vena Cava, Inferior , Humans , Female , Middle Aged , Vena Cava, Inferior/pathology , Sarcoma/drug therapy , Antibodies, Monoclonal, Humanized/therapeutic use , Antibodies, Monoclonal, Humanized/administration & dosage , Vascular Neoplasms/drug therapy , Vascular Neoplasms/pathology , Vascular Neoplasms/diagnosis , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Gemcitabine , Deoxycytidine/analogs & derivatives , Deoxycytidine/therapeutic use , Deoxycytidine/administration & dosage , Lung Neoplasms/drug therapy , Lung Neoplasms/secondary , Lung Neoplasms/pathology
3.
Cancer Lett ; 587: 216725, 2024 Apr 10.
Article in English | MEDLINE | ID: mdl-38364963

ABSTRACT

Next-generation androgen receptor signaling inhibitors (ARSIs), such as enzalutamide (Enza) and darolutamide (Daro), are initially effective for the treatment of advanced prostate cancer (PCa) and castration-resistant prostate cancer (CRPC). However, patients often relapse and develop cross-resistance, which consequently makes drug resistance an inevitable cause of CRPC-related mortality. By conducting a comprehensive analysis of GEO datasets, CRISPR genome-wide screening results, ATAC-seq data, and RNA-seq data, we systemically identified PAK1 as a significant contributor to ARSI cross-resistance due to the activation of the PAK1/RELA/hnRNPA1/AR-V7 axis. Inhibition of PAK1 followed by suppression of NF-κB pathways and AR-V7 expression effectively overcomes ARSI cross-resistance. Our findings indicate that PAK1 represents a promising therapeutic target gene for the treatment of ARSI cross-resistant PCa patients in the clinic. STATEMENT OF SIGNIFICANCE: PAK1 drives ARSI cross-resistance in prostate cancer progression.


Subject(s)
Prostatic Neoplasms, Castration-Resistant , Male , Humans , Prostatic Neoplasms, Castration-Resistant/drug therapy , Prostatic Neoplasms, Castration-Resistant/genetics , Prostatic Neoplasms, Castration-Resistant/metabolism , Receptors, Androgen/metabolism , Clustered Regularly Interspaced Short Palindromic Repeats , Early Detection of Cancer , Neoplasm Recurrence, Local/genetics , Nitriles/pharmacology , Drug Resistance, Neoplasm/genetics , Cell Line, Tumor , p21-Activated Kinases/genetics , p21-Activated Kinases/metabolism
4.
Front Oncol ; 13: 1269118, 2023.
Article in English | MEDLINE | ID: mdl-37920157

ABSTRACT

Background: Recently, the survival rate of nasopharyngeal carcinoma (NPC) patients has improved greatly due to developments in NPC treatments. But cause-specific mortality in NPC patients remains unclear. This study aims to investigate the common causes of death in NPC patients. Methods: Eligible patients with NPC were included from the Surveillance, Epidemiology, and End Results (SEER) database. Standardized mortality ratios(SMRs) were calculated to compare death rates in NPC patients with those in the general population. Results: A total of 3475 patients with NPC were included, of whom 1696 patients died during the follow-up period. 52.83% of deaths were caused by NPC, followed by other cancers (28.13%) and non-cancer causes (18.46%). The proportion of patients who died of NPC decreased over survival time. Moreover, non-cancer causes of death increase from 12.94% to 51.22% over time after 10 years of diagnosis. Heart diseases was the most common non-cancer cause of death in NPC patients. Conclusions: Although NPC remains the leading cause of death after NPC diagnosis, other non-NPC causes of death represent an increased number of death in NPC patients. These findings support the involvement of multidisciplinary care for follow-up strategy in NPC patients.

5.
Clin Med Insights Oncol ; 17: 11795549231201122, 2023.
Article in English | MEDLINE | ID: mdl-37869472

ABSTRACT

Background: The early detection of clinically significant prostate cancer (csPCa) through the integration of multidimensional parameters presents a promising avenue for improving survival outcomes for this fatal disease. This study aimed to assess the contribution of prostate transition zone (TZ) to predictive models based on the prostate health index (PHI), with the goal of enhancing early detection of csPCa in the prostate-specific antigen (PSA) gray zone. Methods: In this observational cross-sectional study, a total of 177 PSA gray zone patients (total prostate-specific antigen [tPSA] level ranging from 4.0 to 10.0 ng/mL) were recruited and received PHI detections from August 2020 to March 2022. Prostatic morphologies especially the TZ morphological parameters were measured by transrectal ultrasound (TRUS). Results: Univariable logistic regression indicated prostatic morphological parameters including total prostate volume (PV) indexes and transitional zone volume indexes were all associated with csPCa (P < .05), while the multivariable analysis demonstrated that C-reactive protein (CRP), PHI, PHI density (PHID), and PHI transition zone density (PHI-TZD) were the 4 independent risk factors. The receiver-operating characteristic (ROC) curve analysis suggested that integrated predictive models (PHID, PHI-TZD) yield area under the curves (AUCs) of 0.9135 and 0.9105 in csPCa prediction, which shows a relatively satisfactory predictive capability compared with other predictors. Moreover, the PHI-TZD outperformed PHID by avoiding 30 patients' unnecessary biopsies while maintaining 74.36% specificity at a sensitivity of 90%. Decision-curve analysis (DCA) confirmed the comparable performance of the multivariable full-risk prediction models, without the inclusion of the net benefit, thereby highlighting the superior diagnostic efficacy of PHID and PHI-TZD in comparison with other diagnostic models, in both univariable and multivariable models. Conclusion: Our data confirmed the value of prostate TZ morphological parameters and suggested a significant advantage for the TZ-adjusted PHI predictive model (PHI-TZD) compared with PHI and PHID in the early detection of gray zone csPCa under specific conditions.

6.
Article in English | MEDLINE | ID: mdl-36229372

ABSTRACT

OBJECTIVE: To investigate how cone beam computed tomography (CBCT) affects the therapeutic planning of impacted maxillary canines. STUDY DESIGN: A total of 132 impacted canines from 89 pediatric patients were collected from 3 specialist clinics in Stockholm, Sweden. An interdisciplinary therapy planning team consisting of 5 dental specialists evaluated each case and chose their preferred treatment alternative, initially without and later with CBCT images, to decide whether CBCT was justified for therapy planning. Predefined variables measurable using only 2-dimensional (2D) assessments were analyzed using stepwise logistic regression analyses. RESULTS: The CBCT was considered indicated in 47% of the cases. Additional information from CBCT led to a treatment decision change in 9.8%. Significant 2D predictors for CBCT justification were horizontal canine angulation compared with vertical angulation (odds ratio [OR] = 10.9), extraction strategy involvement (OR = 6.7), and buccally positioned canines compared with palatal (OR = 5.3), central (OR = 25.0), and distal or uncertain positions (OR = 7.7). CONCLUSIONS: The benefit-risk assessment of CBCT for impacted canines may be reinforced by performing and applying justification decisions for CBCT acquisition at the therapeutic thinking level. If preliminary treatment planning motivates further in-depth investigation of either root status or tooth location, a CBCT is indicated.


Subject(s)
Maxilla , Patient Care Planning , Tooth, Impacted , Humans , Cone-Beam Computed Tomography/methods , Cuspid/diagnostic imaging , Maxilla/diagnostic imaging , Palate , Tooth, Impacted/diagnostic imaging , Tooth, Impacted/therapy , Sweden
7.
Indian J Cancer ; 60(4): 512-520, 2023 Oct 01.
Article in English | MEDLINE | ID: mdl-38206083

ABSTRACT

PURPOSE: The specific risk factors of metastatic and nonmetastatic esophageal neuroendocrine carcinoma (NEC) are still uncertain. Whether primary site surgery is necessary for all patients with esophageal NEC is unknown. METHODS: Patients with esophageal NEC in the Surveillance, Epidemiology, and End Results (SEER) database from 2004 to 2014 were selected. STATA 12 was used to analyze the clinical and pathological features of esophageal NEC. RESULTS: In total, 241 patients with esophageal NEC were included. Metastatic patients had shorter overall survival than nonmetastatic patients (6.03 versus 11.90 months, respectively). Prognostic factors varied between metastatic and nonmetastatic esophageal NEC. The location of the primary tumor is a key point for the prognosis of esophageal NEC. For nonmetastatic esophageal NEC, patients with tumors in the upper third of the esophagus had the worst survival, and patients with metastatic esophageal NEC with a primary tumor in the lower part of the esophagus tended to have an increased risk of death. Moreover, age ≥68 years (hazard ratio [HR] = 2.05; 95% confidence interval [CI]: 1.28-3.31; P < 0.01) and large cell carcinoma (HR = 2.79; 95% CI: 1.30-6.00; P < 0.01) were independent risk factors in patients with metastatic esophageal NEC. Primary site resection benefited patients with nonmetastatic esophageal NEC (HR = 0.20; 95% CI: 0.07-0.56; P < 0.01) rather than patients with metastatic esophageal NEC (HR = 0.91; 95% CI: 0.29-2.83; P > 0.05). CONCLUSIONS: Our study presented that primary tumor location is an important risk factor for nonmetastatic esophageal NEC patients. Age and pathological type are important risk factors for patients with metastatic esophageal NEC. Nonmetastatic esophageal NEC will benefit from primary tumor resection. Systematic treatment is recommended for metastatic esophageal NEC.


Subject(s)
Carcinoma, Neuroendocrine , Esophageal Neoplasms , Humans , Aged , Prognosis , Carcinoma, Neuroendocrine/pathology , Esophageal Neoplasms/surgery , Proportional Hazards Models , Risk Factors , Retrospective Studies
8.
Oncol Rep ; 48(3)2022 Sep.
Article in English | MEDLINE | ID: mdl-35894138

ABSTRACT

Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that certain of the Transwell migration assay data shown in Fig. 3A were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article were already under consideration for publication prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 40: 2389­2398, 2018; DOI: 10.3892/or.2018.6624].

9.
Future Oncol ; 18(18): 2289-2300, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35440175

ABSTRACT

Background: Thyroid function abnormality (TFA) is one of the most common toxicities in non-small-cell lung cancer (NSCLC) patients receiving immune checkpoint inhibitors. However, the risk factors related to TFA and the relationship between TFA and prognosis in NSCLC are not fully clarified. Methods: We conducted a retrospective study of patients with advanced NSCLC who were treated with PD-1 inhibitors in Huzhou Central Hospital. Thyroid function test was carried out using electrochemiluminescent bridging immunoassay. The association between TFA and clinical outcome was investigated. Results: A total of 273 patients were included in this study. Patients who experienced TFA had longer progression-free survival (21.9 vs 6.4 months; p < 0.001) and overall survival (44.6 vs 24.1 months; p = 0.02) than patients without TFA. After multivariate analysis, TFA was an independent prognostic factor for progression-free and overall survival (p < 0.05). Conclusion: TFA is associated with better outcome in NSCLC patients who receive immunotherapy.


Many patients with non-small-cell lung cancer are treated with immunotherapy, a type of treatment that uses the body's natural immune system to fight diseases. We conducted a retrospective study of advanced non-small-cell lung cancer patients who were treated with PD-1 inhibitors (a type of immunotherapy) in Huzhou Central Hospital. Thyroid function abnormality (TFA) is one of the common toxicities in patients receiving PD-1 inhibitors. Our study showed that patients who experienced TFA have longer survival times compared with patients without TFA (overall survival, 44.6 vs 24.1 months; p = 0.02). TFA could be an effective predictor of outcome in non-small-cell lung cancer cases being treated with immunotherapy.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Humans , Immune Checkpoint Inhibitors/adverse effects , Immunotherapy , Prognosis , Retrospective Studies , Thyroid Gland
10.
Mater Sci Eng C Mater Biol Appl ; 119: 111521, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33321608

ABSTRACT

Magnesium alloys can work as biomedical materials due to their Young's modules similar to that of bone. Nevertheless, in a human plasma, one of the major drawbacks of these materials is the low corrosion resistance. Here, AZ80 corrosion in the solutions containing chloride, bicarbonate, sulphate and hydrogen phosphate ions were investigated by a short-term immersion test and electrochemical techniques. The results showed that bicarbonate and hydrogen phosphate could retard corrosion rate, while chloride and sulphate accelerated corrosion rate. During the early immersion stage, the corrosion rate increased with the presence of bicarbonate. It was caused by the reaction of bicarbonate and hydroxide promoting the dissolution of magnesium and accelerating corrosion. In the later stage, the reduced corrosion rate was due to the formation of various protective films. The sample formed a new sparse porous MgSO4·5H2O compounds in the sulphate ion solution, which could not effectively prevent chloride ions from entering the matrix and thus accelerated the dissolution of magnesium. With the presence of hydrogen phosphate, magnesium phosphate with a much lower solubility was formed, preferentially precipitated on the surface and was not influenced by the chloride ions. The corrosion mechanisms of magnesium alloys in above ions were proposed.


Subject(s)
Alloys , Magnesium , Biocompatible Materials , Corrosion , Humans , Ions , Materials Testing , Surface Properties
11.
J Int Med Res ; 48(11): 300060520970878, 2020 Nov.
Article in English | MEDLINE | ID: mdl-33203277

ABSTRACT

Collision carcinoma is a rare malignancy that generally occurs in cervical, esophageal, pulmonary, and squamous cell cancers. Few studies have been reported involving endometrial adenocarcinoma and fallopian tube carcinoma. We reported the case of a 58-year-old woman who presented because of irregular vaginal bleeding for more than 1 month. Cervical biopsy suggested moderately differentiated cervical adenocarcinoma, and the patient underwent radical hysterectomy under general anesthesia. However, postoperative pathology and immunohistochemical results indicated a collision tumor comprising endometrial adenocarcinoma (grade I) and primary serous fallopian tube carcinoma. According to the treatment principle of multiple primary tumors, a regimen of paclitaxel combined with carboplatin was administered. The patient also underwent local pelvic radiotherapy to treat lymph node metastasis. One month later, the patient developed brain metastases and died.


Subject(s)
Adenocarcinoma , Carcinoma , Fallopian Tube Neoplasms , Uterine Neoplasms , Adenocarcinoma/diagnostic imaging , Adenocarcinoma/surgery , Fallopian Tube Neoplasms/diagnostic imaging , Fallopian Tube Neoplasms/drug therapy , Fallopian Tube Neoplasms/surgery , Fallopian Tubes , Female , Humans , Middle Aged
12.
Materials (Basel) ; 13(18)2020 Sep 08.
Article in English | MEDLINE | ID: mdl-32911692

ABSTRACT

AlSi10Mg alloy branches were fabricated by selective laser melting (SLM), and the branches were employed to evaluate their effect on the mechanical properties. When the porous branches were compressed along its building direction, the tree column structures-type AlSi10Mg alloy branches collapsed twice, which had typical elastic, shear, collapse, and densification stages. The compressive stress concentration at the interface between the support and the porous body caused the fracture of the tree column structures-type AlSi10Mg alloy branches. The fracture surface indicated that the prepared tree-type branches were distributed with different shapes of dimples, and the Si content inside the dimples was higher than that of the edge. The morphology of the Al-Si eutectic structure formed by SLM and the stress concentration at the Al/Al-Si-eutectic interface affected the fracture morphology and Si content distribution.

13.
Support Care Cancer ; 28(11): 5569-5579, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32361828

ABSTRACT

PURPOSE: The aim of this study was to evaluate the nutrition and metabolism status alteration during immunotherapy in advanced hepatocellular carcinoma (HCC) patients. METHODS: Patients with advanced HCC who participated in the clinical trials of single-agent anti-PD-1 immunotherapy or sorafenib were retrospectively included. We analyzed self-comparison of the nutritional and metabolic indices of patients in the anti-PD-1 and sorafenib treatment group. We conducted mutual-comparison of the mentioned indices between the disease progression group and disease control group among anti-PD-1 treatment patients. We further analyzed those indices with statistical differences by partial correlation and survival analysis. RESULTS: Both self-comparison before and after treatment in the anti-PD-1 group and mutual-comparison of disease progression and the control group showed significant differences in multiple indices, but we did not observe significant differences in the sorafenib group. Strikingly, albumin (ALB)/prognostic nutritional index (PNI, calculated by serum albumin and lymphocyte count) decreased distinctly in the immunotherapy disease progression group patients. However, changes in ALB/PNI were not significant in disease progression patients from the sorafenib group or in the disease control patients with immunotherapy. Partial correlation analysis suggested that ALB and PNI were positively correlated with the efficacy of immunotherapy. Furthermore, survival analysis showed that the median progression-free survival and median overall survival of patients in the ALB/PNI decreased group were significantly shorter than those of patients from the ALB/PNI increased group. CONCLUSION: Anti-PD-1 immunotherapy might alter the nutritional and metabolic status in advanced HCC patients. We also should pay attention to the nutritional and metabolic status of patients when drug resistance is detected.


Subject(s)
Antineoplastic Agents, Immunological/therapeutic use , Carcinoma, Hepatocellular/drug therapy , Carcinoma, Hepatocellular/metabolism , Liver Neoplasms/drug therapy , Liver Neoplasms/metabolism , Programmed Cell Death 1 Receptor/antagonists & inhibitors , Female , Humans , Immunotherapy , Male , Middle Aged , Nutrition Assessment , Nutritional Status , Prognosis , Retrospective Studies , Sorafenib/therapeutic use , Survival Analysis
14.
Materials (Basel) ; 12(6)2019 Mar 21.
Article in English | MEDLINE | ID: mdl-30901913

ABSTRACT

In order to improve the abrasion performance of 316Lss, make full use of its advantages and broaden its application fields, the tribological behavior of the TiC particles reinforced 316Lss composites-which were manufactured by selective laser melting (SLM)-were investigated. In this study, GCr15 bearing steel was selected as the friction material and experiments on the sliding friction and wear under different loads of 15 N, 25 N and 35 N at the sliding speeds of 60, 80 and 100 mm/min were carried out, respectively. The results show that the wear performance of the TiC/316Lss composite is higher than that of the matrix during the friction and wear experiments under all conditions and the wear rate of the TiC/316Lss composite decreases with increasing the friction rate. Similar to the wear mechanism under different loads, it changes from abrasive wear to delamination wear and severe oxidative wear. At the same time, the mechanical mixed layer formed at a high speed has a protective effect on the matrix. The reason for this phenomenon is that the mechanical properties of the TiC/316Lss composites are significantly improved due to the addition of TiC particles, the refinement of cells near the TiC particles and the formation of a large number of dislocations. In addition, due to the presence of the TiC particles, the hardness and strength of the TiC/316Lss composites are greatly improved, thus the processing hardening ability of sub-surface has been improved.

15.
Anat Rec (Hoboken) ; 302(9): 1552-1560, 2019 09.
Article in English | MEDLINE | ID: mdl-30417983

ABSTRACT

Colorectal cancer (CRC) is one of the common human malignancies. Discovery and identification of novel therapeutic target is imperative to improve the prognosis of CRC patients. As a member of the PIM family, PIM3 has been found to be overexpressed in a variety of cancerous tumors. In this study, we evaluated the expression of PIM3 in CRC tissues and analyzed the role of PIM3 in CRC. Our results showed that PIM3 expression was significantly higher in CRC tissues compared with adjacent noncancerous tissues. The PIM3 expression level was found to be correlated with advanced disease stage and lymph node metastasis. Moreover, PIM3 was found to be able to predict poor prognosis in CRC patients as an independent factor. In vitro studies also showed that knockdown of PIM3 exhibited inhibitory effect on cell growth, promoted cell apoptosis and dampened invasive capability of HCT116 and SW620 cells. Moreover, PIM3 knockdown was able to delay tumor growth and suppress lung metastasis in xenograft model. Our results indicated that PIM3 is a potential therapeutic target for CRC. Anat Rec, 302:1552-1560, 2019. © 2018 American Association for Anatomy.


Subject(s)
Apoptosis , Biomarkers, Tumor/metabolism , Cell Movement , Colorectal Neoplasms/pathology , Lung Neoplasms/secondary , Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins/metabolism , Animals , Biomarkers, Tumor/genetics , Cell Proliferation , Colorectal Neoplasms/genetics , Colorectal Neoplasms/metabolism , Female , Gene Expression Regulation, Neoplastic , Humans , Lung Neoplasms/genetics , Lung Neoplasms/metabolism , Lymphatic Metastasis , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Middle Aged , Neoplasm Invasiveness , Prognosis , Protein Serine-Threonine Kinases/genetics , Proto-Oncogene Proteins/genetics , Tumor Cells, Cultured , Xenograft Model Antitumor Assays
16.
Oncol Rep ; 40(4): 2389-2398, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30106442

ABSTRACT

An increasing number of studies have reported that microRNAs (miRNAs) are dysregulated in cervical cancer and serve critical roles in cervical oncogenesis and progression. Therefore, identifying the aberrantly expressed miRNAs implicated in the formation and progression of cervical cancer may provide key clues for the development of effective therapeutic targets in treating patients with this type of malignancy. In the present study, miRNA­874 (miR­874) was downregulated in cervical cancer tissues and cell lines, and this downregulation was associated with International Federation of Gynaecology and Obstetrics stage and lymph node metastasis. The restored expression of miR­874 prohibited the proliferation, migration and invasion, but promoted the apoptosis of cervical cancer cells. In addition, E26 transformation specific­1 (ETS1) was identified as the direct target of miR­874 in cervical cancer. Inhibition of ETS1 served tumour­suppressive roles similar to miR­874 overexpression in cervical cancer cells. A series of rescue experiments revealed that restoring ETS1 expression abolished the tumour­suppressing effects of miR­874 in cervical cancer cells. Taken together, the results of the present study indicated that miR­874 may serve as a tumour suppressor in cervical cancer by directly targeting ETS1. This function suggested that miR­874 holds potential therapeutic applications in treating patients with this type of malignancy.


Subject(s)
Biomarkers, Tumor/metabolism , Cell Proliferation , MicroRNAs/genetics , Proto-Oncogene Protein c-ets-1/metabolism , Uterine Cervical Neoplasms/pathology , Apoptosis , Biomarkers, Tumor/genetics , Case-Control Studies , Cell Movement , Disease Progression , Female , Follow-Up Studies , Gene Expression Regulation, Neoplastic , Humans , Lymphatic Metastasis , Middle Aged , Neoplasm Invasiveness , Prognosis , Proto-Oncogene Protein c-ets-1/genetics , Tumor Cells, Cultured , Uterine Cervical Neoplasms/genetics , Uterine Cervical Neoplasms/metabolism
17.
Materials (Basel) ; 11(9)2018 Aug 24.
Article in English | MEDLINE | ID: mdl-30149554

ABSTRACT

In this paper, GH4169 alloy's distributions of temperature and stress during the selective laser melting (SLM) process were studied. The SLM process is a dynamic process of rapid melting and solidification, and we found there were larger temperature gradients near the turning of scan direction and at the overlap of the scanning line, which produced thermal strain and stress concentration and gave rise to warping deformations. The stresses increased as the distance became further away from the melt pool. There was tensile stress in the most-forming zones, but compressive stress occurred near the melt pool area. When the parts were cooled to room temperature after the SLM process, tensile stress was concentrated around the parts' boundaries. Residual stress along the z direction caused the warping deformations, and although there was tensile stress in the parts' surfaces, but there was compressive stress near the substrate.

18.
Int J Oncol ; 48(6): 2257-64, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27035407

ABSTRACT

Tongue diagnosis, as a unique method of traditional Chinese medicine (TCM), was used to discriminate physiological functions and pathological conditions by observing the changes of the tongue and tongue coating. The aims of the present study were to explore a potential screening and early diagnosis method of cancer through evaluating the differences of the images of tongue and tongue coating and the microbiome on the tongue coating. The DS01-B tongue diagnostic information acquisition system was used to photograph and analyze the tongue and tongue coating. The next-generation sequencing technology was used to determine the V2-V4 hypervariable regions of 16S rDNA to investigate the microbiome on the tongue coating. Bioinformatics and statistical methods were used to analyze the microbial community structure and diversity. Comparing with the healthy people, the number of mirror-like tongue, thick tongue coating and the moisture of tongue were increased in cancers. The dominant color of the tongue in the healthy people was reddish while it was purple in the cancers. The relative abundance of Neisseria, Haemophilus, Fusobacterium and Porphyromonas in the healthy people were higher than that in the cancers. We also found 6 kinds of special microorganisms at species level in cancers. The study suggested that tongue diagnosis may provide potential screening and early diagnosis method for cancer.


Subject(s)
Neoplasms/diagnosis , Tongue/diagnostic imaging , Tongue/microbiology , Case-Control Studies , Computational Biology , Early Detection of Cancer/methods , Female , Humans , Male , Medicine, Chinese Traditional/methods , Microbiota/genetics , Middle Aged , Neoplasms/diagnostic imaging , Neoplasms/microbiology , RNA, Ribosomal, 16S/genetics
19.
Biomaterials ; 24(4): 649-54, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12437959

ABSTRACT

The role of surface microtopography in combination with different surface wettability for rat calvaria cell differentiation was examined. Mineralization and alkaline phosphatase (ALP) activity of rat calvaria cells on flat polydimethylsiloxane (PDMS) or PDMS contained pyramids which were either hydrophilic or hydrophobic were compared. ALP expressing cells were more frequent on hydrophilic PDMS contained pyramids. ALP activity, peaked at day 9, was highest for hydrophilic pyramids followed by hydrophobic pyramids and flat hydrophilic PDMS surfaces. A similar pattern was obtained with respect to mineralized nodules. These observations showed that micro-sized surface features promote differentiation of rat calvaria cells. Further, hydrophilic surfaces are more prone to stimulate differentiation in comparison with hydrophobic surfaces. The results suggest that both material surface chemistry and topography affect osteoblast differentiation.


Subject(s)
Cell Differentiation/physiology , Coated Materials, Biocompatible/metabolism , Osteoblasts/metabolism , Alkaline Phosphatase/metabolism , Animals , Animals, Newborn , Cell Culture Techniques/methods , Dimethylpolysiloxanes/metabolism , Microscopy, Electron, Scanning , Osteoblasts/cytology , Rats , Silicones/metabolism , Skull/cytology , Staining and Labeling , Surface Properties , Wettability
20.
Biomaterials ; 23(13): 2693-701, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12059018

ABSTRACT

The interface of bone and aragonite nacre (Margaritifera, fresh water pearl mussel) was studied by in situ hybridization and a tartrate-resistant acid phosphatase (TRAP) histochemical assay. Columnar implants were inserted into rat femora for 4, 7, 14, 28 and 56 days. In medullary region, a burst of transient bone formation was observed, which propagated from the periphery towards the nacre implant. A fused interface of bone and nacre was observed at 14 days. Later, the new medullary bone was resorbed and bone marrow was re-established while a thin layer of bone tissue remained covering the implant surface. Expressions of collagen alpha1(I), osteocalcin, osteopontin mRNAs and TRAP in the surrounding tissue were monitored. Correlated with the histology events, a strong transient induction of collagen alpha1(I) and osteocalcin mRNAs as well as TRAP expression, exhibiting a peak signal intensity on day 7 and subsequent down-regulation after day 14 was observed. Osteopontin mRNA, in contrast, was expressed continuously. The degrading nacre surface appeared in direct contact with macrophages and multinucleated giant cells at both days 14 and 28. These cells expressed osteopontin mRNA intensively and some TRAP enzyme activity occasionally.


Subject(s)
Biocompatible Materials/chemistry , Bone Substitutes/chemistry , Calcium Carbonate/pharmacology , Femur/metabolism , Sialoglycoproteins/biosynthesis , Acid Phosphatase/metabolism , Animals , Collagen/biosynthesis , Giant Cells/metabolism , In Situ Hybridization , Isoenzymes/metabolism , Male , Osteocalcin/biosynthesis , Osteopontin , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Tartrate-Resistant Acid Phosphatase , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL